BIOMEDICAL RESEARCH:
Australia Pushes Stem Cell Advantage
Leigh Dayton
SYDNEY--Australia's new policy on embryonic stem (ES) cells has already started to pay big dividends for researchers. Last week the government announced that it will invest $25 million in a new Center for Stem Cells and Tissue Repair at Monash University in Melbourne that will work to develop therapies for blood and tissue diseases based on new and existing ES cell lines.